Associations of corticosteroid therapy with weight change and appetite in patients with advanced pancreatic cancer – a post hoc analysis from the MISTRAL trial
In long-term follow-up, corticosteroid treatment was associated with greater weight loss and poorer appetite among patients with advanced pancreatic cancer. These findings may partly be explained by a higher symptom burden among patients receiving corticosteroids. Future prospective trials are warranted to clarify the effect of long-term corticosteroid treatment on weight and appetite.
Authors
- Charlotte Goodrose-Flores (ORCID: https://orcid.org/0000-0002-0253-7819)
- Stephanie E. Bonn (ORCID: https://orcid.org/0000-0002-2219-7970)
- Kathrin Wode (ORCID: https://orcid.org/0000-0001-6449-6349)
- Linda Björkhem-Bergman
Institutions
- Swedish Foundation for Strategic Research (SE)
- Karolinska Institutet (SE)
- Integrated Cardio Metabolic Centre (SE)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1007/s00520-026-10585-2
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00